Compare ADMA Biologics Inc (ADMA) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Citius Pharmaceuticals Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: ADMA Biologics Inc is far larger — about 110.9× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| ADMA | CTXR | |
|---|---|---|
Market Cap | $2.22B | $20.01M |
Sector | Health | Health |
52-Week High | $20.38 | $1.82 |
52-Week Low | $7.60 | $0.48 |
Enterprise Value | $2.29B | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
